Reality CHEK: Understanding the biology and clinical potential of CHK1

Fiifi Neizer-Ashun1, Resham Bhattacharya2

  • 1Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK, 73104, United States.

Cancer Letters
|September 29, 2020
PubMed

Insights

The DNA damage response relies on CHK1 (a serine/threonine kinase) for genomic integrity. Targeting CHK1 offers potential cancer therapies, though clinical applications are still developing.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The DNA damage response (DDR) is crucial for maintaining genomic stability.
  • The serine/threonine kinase CHK1, encoded by the CHEK1 gene, is a key regulator in the DDR.
  • CHK1 is involved in cell cycle checkpoints, DNA replication, repair, and mitosis.

Purpose of the Study:

  • To review the fundamental roles of CHK1 in cellular processes.
  • To explore the therapeutic potential of targeting CHK1 in cancer treatment.
  • To highlight current challenges and future directions for CHK1-targeted cancer therapy.

Main Methods:

  • Literature review of CHK1 function and DDR pathways.
  • Analysis of existing research on CHK1's role in cell cycle regulation and DNA repair.
  • Exploration of preclinical and clinical studies investigating CHK1 inhibitors.

Main Results:

  • CHK1 plays multifaceted roles beyond the G2/M checkpoint, including DNA replication and repair.
  • Dysregulation of CHK1 is implicated in various cancers.
  • CHK1 inhibitors show promise but face challenges in clinical translation.

Conclusions:

  • CHK1 is a critical node in the DNA damage response with significant implications for cancer.
  • Further research is needed to optimize CHK1-targeting strategies for effective cancer therapy.
  • Understanding CHK1's complex roles is essential for realizing its full therapeutic potential.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.3K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.1K